Product How it works Pricing Blog FAQ About Contact
Español English
EspañolEnglish
Log inCreate free account
Chemed

Chemed (NYSE: CHE) insider transactions

In the twelve months to 10 November 2026, executives and directors of Chemed reported 15 open-market sales of 21,517 shares ($10.3m) and 0 open-market purchases, by 5 people, according to the Form 4 filings they submitted to the SEC.

Latest transactions

The 20 most recent transactions in Chemed shares reported on Form 4
DateInsiderRoleTransactionSharesPriceHeld afterFiling
3 November 2026McNamara Kevin Jpresident and CEOOpen-market sale−2,000$537.9082,220Form 4
2 November 2026Lee Spencer Sexecutive vice presidentOpen-market sale−920$537.1713,931Form 4
30 September 2026Lee Spencer Sexecutive vice presidentOption exercise+12,099$445.3526,011Form 4
30 September 2026Lee Spencer Sexecutive vice presidentShares withheld for tax−11,160$508.9314,851Form 4
28 September 2026McNamara Kevin Jpresident and CEOOpen-market sale−2,000$513.4566,418Form 4
28 September 2026Hutton Thomas Cvice presidentOption exercise+4,629$445.3537,110Form 4
28 September 2026Hutton Thomas Cvice presidentShares withheld for tax−4,270$506.6532,840Form 4
18 September 2026McNamara Kevin Jpresident and CEOOpen-market sale−2,000$501.4068,418Form 4
21 August 2026McNamara Kevin Jpresident and CEOOpen-market sale−2,000$541.1670,418Form 4
21 August 2026Lee Spencer Sexecutive vice presidentOpen-market sale−1,000$541.0413,912Form 4
10 August 2026Judkins Brian CVP and Chief Legal OfficerOption exercise+6,786$445.359,222Form 4
10 August 2026Judkins Brian CVP and Chief Legal OfficerShares withheld for tax−5,878$548.963,344Form 4
5 August 2026Wherley Joel LCEO - Vitas HealthcareOption exercise+2,599$445.353,451Form 4
5 August 2026Wherley Joel LCEO - Vitas HealthcareShares withheld for tax−2,270$542.621,181Form 4
3 August 2026McNamara Kevin Jpresident and CEOOpen-market sale−2,000$539.5170,418Form 4
31 July 2026McNamara Kevin Jpresident and CEOOption exercise+2,001$445.3592,220Form 4
31 July 2026McNamara Kevin Jpresident and CEOShares withheld for tax−19,802$529.2272,418Form 4
31 July 2026Grace Patrick PDirectorOpen-market sale−190$532.003,533Form 4
9 June 2026Lindell Andrea RDirectorOpen-market sale−1,347$447.334,578Form 4
29 May 2026Walsh George J IiiDirectorOpen-market sale−500$437.833,209Form 4

Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.

How to read the table

Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.

Where each row comes from

From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Chemed page; the method, in data sources.

Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.